MedPath

INVSENSOR00027 Fall Detection Clinical Performance Study

Not Applicable
Completed
Conditions
Healthy
Interventions
Device: INVSENSOR00027
Registration Number
NCT04224753
Lead Sponsor
Masimo Corporation
Brief Summary

This study assesses INVSENSOR00027's clinical performance for fall detection.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • 18 to 45 years old
  • Physical status of ASA I or II
  • Subjects must be able to read and communicate in English
  • Has signed all necessary related documents, e.g. written informed consent, volunteer payment form, confidentiality agreement
  • Has completed Health Assessment Questionnaire and passed health assessment screening
Exclusion Criteria
  • Subject has any medical condition which in the judgment of the investigator, renders them inappropriate for participation in this study
  • Inability to tolerate physical activities including jumping and fall simulation
  • Nursing female volunteers
  • Excluded at the Principal Investigator's discretion
  • Refusal to take the pregnancy test (for female subjects)
  • Positive pregnancy test for female subjects of child bearing potential. This is done for the safety of this population.
  • Refusal to shave hair (chest) off areas where sensors will be applied (male subjects)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
INVSENSOR00027 Test groupINVSENSOR00027The subjects will be enrolled into the test group and will receive the INVSENSOR00027 investigational sensor.
Primary Outcome Measures
NameTimeMethod
Sensitivity of INVSENSOR00027's Fall Detection.1-5 hours

For each subject's fall simulation, INVSENSOR00027 output will be computed. In order to calculate sensitivity of the device, true positives and false negatives need to be accounted for. For each event of fall, the sensor's output is observed. Fall that is correctly identified is marked as true positive (TP), whereas a missed detection is marked as false negative (FN). Combining the two, test sensitivity is computed by multiplying TP by 100 and dividing that over the sum of TP and FN.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Masimo Clinical Lab

🇺🇸

Irvine, California, United States

© Copyright 2025. All Rights Reserved by MedPath